Pulmonx (LUNG) Share-based Compensation (2019 - 2025)

Pulmonx (LUNG) has 7 years of Share-based Compensation data on file, last reported at $5.2 million in Q3 2025.

• On a quarterly basis, Share-based Compensation rose 638.0% year-over-year to $5.2 million in Q3 2025; TTM through Sep 2025 was $22.5 million, a 77.69% increase from a year earlier, with the FY2024 full-year figure at $23.0 million, up 3.86% from the prior year.
• Share-based Compensation for Q3 2025 stood at $5.2 million, down from $6.2 million in the prior quarter.
• Over the last five years, Share-based Compensation for LUNG reached as high as $16.3 million in Q4 2022 and fell as low as -$3.4 million in Q2 2022.
• Historically, Share-based Compensation has averaged $4.1 million across 5 years, with a median of $5.2 million in 2025.
• Across the five-year window, Share-based Compensation slumped 531.18% in 2021 and surged 11226.42% in 2023, its largest moves.
• Year by year, Share-based Compensation stood at $9.3 million in 2021, then jumped by 75.43% to $16.3 million in 2022, then tumbled by 65.56% to $5.6 million in 2023, then declined by 1.34% to $5.5 million in 2024, then declined by 6.46% to $5.2 million in 2025.
• Per Business Quant data, the three most recent Share-based Compensation figures were $5.2 million in Q3 2025, $6.2 million in Q2 2025, and $5.6 million in Q1 2025.